Stefano Di Cecca

6PUBLICATIONS
50CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 03, 2026
Anti-CD7 fratricide-resistant chimeric antigen receptor T cells for relapsed/refractory acute myeloid leukemia.

Marco Becilli, Pietro Merli, Mattia Algeri

|Jun 25, 2025
Point-of-care fresh CAR T cells for pediatric or young adult BCP-ALL that is relapsed/refractory or in very-high-risk first relapse.

Francesca Del Bufalo, Marco Becilli, Chiara Rosignoli

|Mar 29, 2024
GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma.

Roselia Ciccone, Concetta Quintarelli, Antonio Camera

|May 12, 2023
Allogeneic, donor-derived, second-generation, CD19-directed CAR-T cells for the treatment of pediatric relapsed/refractory BCP-ALL.

Francesca Del Bufalo, Marco Becilli, Chiara Rosignoli

|Jun 24, 2022
T-Cell Defects Associated to Lack of Spike-Specific Antibodies after BNT162b2 Full Immunization Followed by a Booster Dose in Patients with Common Variable Immune Deficiencies.

Federica Pulvirenti, Stefano Di Cecca, Matilde Sinibaldi

|Jun 24, 2022
Clinical and Molecular Spectrum of Sporadic Vascular Malformations: A Single-Center Study.

Andrea Diociaiuti, Roberta Rotunno, Elisa Pisaneschi

Pageof 1

Frequent Collaborators

4 joint publications

Concetta Quintarelli

4 joint publications

Biagio De Angelis

4 joint publications

Marco Becilli

3 joint publications

Valentina Bertaina